C71T
CANCELLED SECTION 71
01/16/2026
Back to search
Official data from USPTO
REGENERA THERAPEUTIC LENS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
02/10/2026
Trademark type
Combined
Nice classes
9
Filing date
05/24/2018
Registration date
07/02/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/16/2026
Last transaction
02/10/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
09
Owner location
IT
Examiner
CIANCI, RYAN MICHAEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The trademark consists of the words "REGENERA THERAPEUTIC LENS" in fancy characters; the word "REGENERA" is bigger and the first two letters, "R" and "E", are in grey; the remaining part "GENERA" is in green; the words "THERAPEUTICS LENS" are grey, smaller and put them below "GENERA"; below letters "R" and "E" of "REGENERA", there is the stylization of a green contact lens.
Holders and representatives
Holders
Eye Pharma S.p.A.
Representatives
Michael N. Mercanti LUCAS & MERCANTI, LLP
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Contact lenses; ophthalmic lenses
Publications
History of USPTO decisions and trademark events.
24 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/21/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/02/2024
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
10/25/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/10/2019
FIMP
FINAL DISPOSITION PROCESSED
10/10/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/02/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2019
PUBO
PUBLISHED FOR OPPOSITION
04/16/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2019
RFNT
REFUSAL PROCESSED BY IB
02/22/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/20/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/20/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/06/2019
RFRR
REFUSAL PROCESSED BY MPU
02/06/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/24/2019
CNRT
NON-FINAL ACTION WRITTEN
01/23/2019
MAFR
APPLICATION FILING RECEIPT MAILED
01/22/2019
DOCK
ASSIGNED TO EXAMINER
01/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/16/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/10/2019
Continuous trademark protection
Get notified about every new filing that threatens REGENERA THERAPEUTIC LENS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.